Based on the regulatory role of OCN in the hippocampus and its protection of age-related cognitive dysfunctions, our study aimed to explore whether OCN can ameliorate the cognitive dysfunctions in a mouse model of AD and investigate the potential mechanisms, trying to expand the endocrine functions of OCN and providing a new dimension for the treatment of AD. Here, BGLAP is linked to Alzheimer disease.